A Year in Review: Atrial Fibrillation 2023.
作者信息
Ahmad Amier, Karnik Ankur A, Doshi Rahul
机构信息
Department of Clinical Cardiac Electrophysiology, Scottsdale, AZ, USA.
出版信息
J Innov Card Rhythm Manag. 2024 Jan 15;15(1):5704-5708. doi: 10.19102/icrm.2024.15017. eCollection 2024 Jan.
Abstract
摘要
相似文献
1
A Year in Review: Atrial Fibrillation 2023.2023年回顾：心房颤动
J Innov Card Rhythm Manag. 2024 Jan 15;15(1):5704-5708. doi: 10.19102/icrm.2024.15017. eCollection 2024 Jan.
2
One-stop procedure of "Atrial fibrillation radiofrequency ablation + left atrial appendage closure" guided by 3D printing technology: A case report.3D 打印技术引导下一站式“房颤射频消融+左心耳封堵”术：1 例报告。
Echocardiography. 2023 Aug;40(8):856-861. doi: 10.1111/echo.15572. Epub 2023 Jun 16.
3
Safety and feasibility of combined atrial fibrillation ablation and left atrial appendage occlusion after left atrial appendage electrical isolation.左心耳电隔离后同期行心房颤动消融与左心耳封堵的安全性和可行性。
J Interv Card Electrophysiol. 2020 Jan;57(1):43-55. doi: 10.1007/s10840-019-00603-1. Epub 2019 Aug 3.
4
Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.左心耳封堵术联合导管消融治疗心房颤动：一项多国注册研究的2年结果
Europace. 2020 Feb 1;22(2):225-231. doi: 10.1093/europace/euz286.
5
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.经皮左心耳封堵术用于房颤且有抗凝禁忌证患者的卒中预防
Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23.
6
Effect of catheter ablation combined with left appendage occlusion for non-valvular atrial fibrillation: a meta-analysis.导管消融联合左心耳封堵治疗非瓣膜性心房颤动的效果：一项荟萃分析。
J Cardiothorac Surg. 2022 May 31;17(1):132. doi: 10.1186/s13019-022-01885-9.
7
Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.使用Watchman左心耳封堵装置的房颤患者的导管消融：多中心注册研究结果
J Cardiovasc Electrophysiol. 2017 Feb;28(2):139-146. doi: 10.1111/jce.13148. Epub 2017 Jan 19.
8
Left atrial catheter ablation subsequent to Watchman® left atrial appendage device implantation: a single centre experience.在植入Watchman®左心耳封堵装置后进行左心房导管消融：单中心经验
Europace. 2015 Sep;17(9):1402-6. doi: 10.1093/europace/euv037. Epub 2015 May 21.
9
Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation.左心耳封堵术预防非瓣膜性心房颤动所致卒中。
J Am Heart Assoc. 2021 Nov 2;10(21):e022274. doi: 10.1161/JAHA.121.022274. Epub 2021 Oct 20.
10
Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience.心房颤动联合导管消融与Watchman®左心耳封堵术：五年经验
J Arrhythm. 2016 Apr;32(2):119-26. doi: 10.1016/j.joa.2015.11.001. Epub 2015 Dec 8.
引用本文的文献
1
Letter from the Editor in Chief.主编来信。
J Innov Card Rhythm Manag. 2025 Jan 15;16(1):A7-A8. doi: 10.19102/icrm.2025.16019. eCollection 2025 Jan.
2
A Year in Review: Atrial Fibrillation 2024.年度回顾：2024年心房颤动
J Innov Card Rhythm Manag. 2025 Jan 15;16(1):6136-6140. doi: 10.19102/icrm.2025.16016. eCollection 2025 Jan.
本文引用的文献
1
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
2
Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.房颤 CHA2DS2-VASC 风险评分 1 分的卒中与出血风险：挪威 AFNOR 研究。
Eur Heart J. 2024 Jan 1;45(1):57-66. doi: 10.1093/eurheartj/ehad659.
3
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.直接口服抗凝剂预防器械检测到的心房颤动患者卒中：NOAH-AFNET 6 和 ARTESiA 试验的研究水平荟萃分析。
Circulation. 2024 Mar 26;149(13):981-988. doi: 10.1161/CIRCULATIONAHA.123.067512. Epub 2023 Nov 12.
4
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.阿哌沙班预防非瓣膜性心房颤动的卒中。
N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234. Epub 2023 Nov 12.
5
One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial.使用Amulet或Watchman装置进行经皮左心耳封堵术后一年的结果：SWISS-APERO随机临床试验的预先设定分析
Circulation. 2024 Feb 6;149(6):484-486. doi: 10.1161/CIRCULATIONAHA.123.067599. Epub 2023 Oct 24.
6
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation.脉冲场或常规热消融治疗阵发性心房颤动。
N Engl J Med. 2023 Nov 2;389(18):1660-1671. doi: 10.1056/NEJMoa2307291. Epub 2023 Aug 27.
7
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.终末期心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2023 Oct 12;389(15):1380-1389. doi: 10.1056/NEJMoa2306037. Epub 2023 Aug 27.
8
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.在伴有心房快速发作的患者中使用依度沙班进行抗凝治疗。
N Engl J Med. 2023 Sep 28;389(13):1167-1179. doi: 10.1056/NEJMoa2303062. Epub 2023 Aug 25.
9
A Randomized Trial of High vs Standard Power Radiofrequency Ablation for Pulmonary Vein Isolation: SHORT-AF.随机试验高 vs 标准功率射频消融肺静脉隔离：SHORT-AF。
JACC Clin Electrophysiol. 2023 Jul;9(7 Pt 2):1038-1047. doi: 10.1016/j.jacep.2022.12.020. Epub 2023 Feb 22.
10
EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry.脉冲场消融治疗有症状心房颤动患者的欧洲真实世界结局：来自多中心 EU-PORIA 注册研究的经验。
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad185.
Zotero 插件